Publication: Synthesis of Novel Mono and Bis-Indole Conduritol Derivatives and Their α/β-Glycosidase Inhibitory Effects
| dc.authorscopusid | 6504284918 | |
| dc.authorscopusid | 8576446300 | |
| dc.authorscopusid | 23027537500 | |
| dc.contributor.author | Çavdar, H. | |
| dc.contributor.author | Talaz, O. | |
| dc.contributor.author | Ekinci, D. | |
| dc.date.accessioned | 2020-06-21T14:17:02Z | |
| dc.date.available | 2020-06-21T14:17:02Z | |
| dc.date.issued | 2012 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Çavdar] Hüseyin, Faculty of Education, Dumlupinar Üniversitesi, Kutahya, Turkey; [Talaz] Oktay, Department of Chemistry, Karamanoğlu Mehmetbey Üniversitesi, Karaman, Karaman, Turkey; [Ekinci] Deniz, Department of Agricultural Biotechnology, Ondokuz Mayis Üniversitesi, Samsun, Turkey | en_US |
| dc.description.abstract | Here we synthesized four novel indole conduritol derivatives 1-4 for the first time in the literature and probed their biological activities with the α and β-glucosidases. The compounds showed quite effective glucosidase inhibitory action. IC<inf>50</inf> values of the compounds were compared with the known glucosidase inhibitor acarbose and it was determined that newly synthesized indole conduritols had more powerful effect against β-glucosidase in addition to exhibiting moderate influence against α-glucosidase. Our molecules thus constitute an important starting point for the design and exploitation of novel glucosidase inhibitors since glucosidase inhibitors have widespread applications in the treatment of diabetes, viral infections, lysosomal storage diseases and cancers. © 2012 Elsevier Ltd. All rights reserved. | en_US |
| dc.identifier.doi | 10.1016/j.bmcl.2012.10.038 | |
| dc.identifier.endpage | 7503 | en_US |
| dc.identifier.issn | 1464-3405 | |
| dc.identifier.issue | 24 | en_US |
| dc.identifier.pmid | 23137433 | |
| dc.identifier.scopus | 2-s2.0-84870237734 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 7499 | en_US |
| dc.identifier.uri | https://doi.org/10.1016/j.bmcl.2012.10.038 | |
| dc.identifier.volume | 22 | en_US |
| dc.identifier.wos | WOS:000311425500044 | |
| dc.identifier.wosquality | Q2 | |
| dc.language.iso | en | en_US |
| dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
| dc.relation.ispartof | Bioorganic & Medicinal Chemistry Letters | en_US |
| dc.relation.journal | Bioorganic & Medicinal Chemistry Letters | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Conduritol | en_US |
| dc.subject | Glucosidase | en_US |
| dc.subject | Indole | en_US |
| dc.subject | Inhibitor | en_US |
| dc.title | Synthesis of Novel Mono and Bis-Indole Conduritol Derivatives and Their α/β-Glycosidase Inhibitory Effects | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
